Marimed (MRMD) Net Cash Flow (2012 - 2026)

Marimed (MRMD) has 15 years of Net Cash Flow data on file, last reported at -$947000.0 in Q1 2026.

• On a quarterly basis, Net Cash Flow fell 1069.14% year-over-year to -$947000.0 in Q1 2026; TTM through Mar 2026 was $736000.0, a 109.16% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 121.76% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$947000.0, down from $2.3 million in the prior quarter.
• Over the last five years, Net Cash Flow for MRMD reached as high as $11.9 million in Q1 2023 and fell as low as -$25.6 million in Q2 2022.
• Historically, Net Cash Flow has averaged -$1.3 million across 5 years, with a median of -$404000.0 in 2024.
• Across the five-year window, Net Cash Flow jumped 213.37% in 2023 and slumped 1069.14% in 2026, its largest moves.
• Year by year, Net Cash Flow stood at -$1.4 million in 2022, then soared by 200.73% to $1.4 million in 2023, then sank by 280.81% to -$2.5 million in 2024, then soared by 191.3% to $2.3 million in 2025, then plunged by 141.39% to -$947000.0 in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$947000.0 in Q1 2026, $2.3 million in Q4 2025, and $458000.0 in Q3 2025.